News Summary: Bristol-Myers, Sanofi alter alliance

Associated Press

NEW DEAL: Bristol-Myers Squibb and France's Sanofi are revamping their longtime partnership marketing some of their best-selling medications, blood thinner Plavix and blood pressure drugs Avapro and Avalide.

THE TIMING: All three drugs got generic competition in the U.S. in the spring. The billions of dollars in annual sales they had generated for years is quickly shrinking.

THE TERMS: Bristol-Myers will keep selling Plavix in the U.S. through December 2019. Sanofi will handle nearly all other sales of the three drugs through 2018 and will give Bristol-Myers royalties from that revenue, plus a one-time payment of $200 million.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You